L1CAM-AS1: A Potential Drug Target and Biomarker (G100996465)

Target Name: L1CAM-AS1

NCBI ID: G100996465

L1CAM-AS1

Other Name(s): LCA10 | LCAP | L1CAM antisense RNA 1

L1CAM-AS1: A Potential Drug Target and Biomarker

L1CAM-AS1 is a protein that is expressed in various tissues of the body, including the brain, pancreas, and gastrointestinal tract. It is a member of the L1 family of cadherins, which are a group of transmembrane proteins that play a crucial role in cell-cell adhesion. L1CAM-AS1 has been shown to be involved in several cellular processes, including cell signaling, migration, and invasion.

Drug Target Potential

The potential drug targets for L1CAM-AS1 are numerous and varied. One of the most promising targets is the regulation of cancer cell growth and survival. L1CAM-AS1 has been shown to be involved in several signaling pathways that promote cancer cell growth, including the TGF-β pathway. This pathway is known to be a major contributor to cancer cell proliferation and survival, and targeting L1CAM-AS1 may be a useful way to treat cancer.

Another potential drug target for L1CAM-AS1 is the regulation of neurodegenerative diseases, such as Alzheimer's disease. L1CAM-AS1 has been shown to be involved in the regulation of neurotransmitter release from nerve cells, which is important for several neurotransmitter systems that are involved in memory and cognitive function. Therefore, targeting L1CAM-AS1 may be a promising approach to treating Alzheimer's disease.

Biomarker Potential

In addition to its potential drug target potential, L1CAM-AS1 may also be a useful biomarker for several diseases. For example, L1CAM-AS1 has been shown to be involved in the regulation of insulin secretion from pancreatic beta cells, which is important for maintaining normal blood sugar levels. Therefore, measuring the levels of L1CAM-AS1 may be a useful diagnostic tool for pancreatic beta-cell dysfunction, which is a common complication in type 2 diabetes.

Another potential use of L1CAM-AS1 as a biomarker is its involvement in cancer progression. L1CAM-AS1 has been shown to be involved in the regulation of cell adhesion and migration, which are important processes that contribute to cancer cell progression. Therefore, measuring the levels of L1CAM-AS1 may be a useful diagnostic tool for cancer recurrence or progression.

Conclusion

In conclusion, L1CAM-AS1 is a protein that is expressed in various tissues of the body and is involved in several cellular processes. Its potential drug targets are numerous and varied, including the regulation of cancer cell growth and survival, and the regulation of neurodegenerative diseases. Additionally, L1CAM-AS1 may be a useful biomarker for several diseases, including pancreatic beta-cell dysfunction, cancer recurrence or progression. Further research is needed to fully understand the role of L1CAM-AS1 in these processes and to develop effective treatments.

Protein Name: L1CAM Antisense RNA 1

The "L1CAM-AS1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about L1CAM-AS1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets